4.7 Letter

Effective Treatment of Acute Severe Ulcerative Colitis in Pregnancy Is Associated With Good Maternal and Fetal Outcomes

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 19, Issue 11, Pages 2444-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2020.10.035

Keywords

-

Funding

  1. AbbVie
  2. Takeda
  3. BMS/Celgene
  4. Boehringer Ingelheim
  5. Crohn's
  6. Colitis Foundation of America
  7. Genentech
  8. Gilead Sciences
  9. Hollister
  10. Medimmune
  11. Mesoblast Ltd,
  12. Osiris Therapeutics
  13. Pfizer
  14. Receptos
  15. RedHill Biopharma
  16. Sanofi-Aventis
  17. Schwarz Pharma
  18. Seres Therapeutics
  19. Takeda Pharma
  20. UCB Pharma

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available